Organon & Co (OGN)
18.07
-0.71
(-3.78%)
USD |
NYSE |
Nov 01, 16:00
18.02
-0.05
(-0.28%)
After-Hours: 20:00
Organon Profit Margin (Quarterly): 22.69% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 22.69% |
| June 30, 2024 | 12.13% |
| March 31, 2024 | 12.39% |
| December 31, 2023 | 34.17% |
| September 30, 2023 | 3.82% |
| June 30, 2023 | 15.05% |
| March 31, 2023 | 11.51% |
| December 31, 2022 | 7.27% |
| September 30, 2022 | 14.77% |
| June 30, 2022 | 14.76% |
| Date | Value |
|---|---|
| March 31, 2022 | 22.21% |
| December 31, 2021 | 12.60% |
| September 30, 2021 | 20.19% |
| June 30, 2021 | 26.77% |
| March 31, 2021 | 26.49% |
| December 31, 2020 | 22.81% |
| September 30, 2020 | 33.91% |
| June 30, 2020 | 35.52% |
| March 31, 2020 | 39.49% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
3.82%
Minimum
Sep 2023
39.49%
Maximum
Mar 2020
20.45%
Average
20.19%
Median
Sep 2021
Profit Margin (Quarterly) Benchmarks
| Eli Lilly and Co | 8.48% |
| Biomarin Pharmaceutical Inc | 14.22% |
| Cassava Sciences Inc | -- |
| Ligand Pharmaceuticals Inc | -125.0% |
| TG Therapeutics Inc | 9.36% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 25.02K% |
| Return on Assets | 10.87% |
| Return on Invested Capital | 14.93% |
| Gross Profit Margin (Quarterly) | 58.34% |
| Operating Margin (Quarterly) | 24.65% |
| Return on Net Operating Assets | 13.91% |